Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 1, Pages 197
Publisher
MDPI AG
Online
2020-01-15
DOI
10.3390/cancers12010197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- (2019) Eileen M. O’Reilly et al. JAMA Oncology
- Surgery for Recurrent Pancreatic Cancer: Is It Effective?
- (2019) Lucia Moletta et al. Cancers
- PL02.04 Blood MicroRNA and LDCT Reduce Unnecessary LDCT Repeats in Lung Cancer Screening: Results of Prospective BioMILD Trial
- (2019) U. Pastorino et al. Journal of Thoracic Oncology
- Serum exosomal microRNAs as potent circulating biomarkers for melanoma
- (2018) Li Tengda et al. MELANOMA RESEARCH
- TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
- (2018) Silvia Ottaviani et al. Nature Communications
- Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma
- (2018) Anda J. Stroese et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma
- (2018) Max Michael Traeger et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients
- (2018) Sandra Santasusagna et al. ONCOLOGY
- Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
- (2018) Sameer Dhayat et al. Cancers
- Integrated extracellular microRNA profiling for ovarian cancer screening
- (2018) Akira Yokoi et al. Nature Communications
- Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells
- (2018) Françoise Boudouresque et al. Oncotarget
- Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma
- (2017) Max M. Träger et al. INTERNATIONAL JOURNAL OF CANCER
- Exosomes: From Garbage Bins to Promising Therapeutic Targets
- (2017) Mohammed H. Rashed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway
- (2017) Long Peng et al. ONCOLOGY REPORTS
- Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer
- (2017) Yi-Fan Xu et al. Oncotarget
- miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial–mesenchymal transition and the Notch signaling pathway
- (2017) Yan Tang et al. Scientific Reports
- Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis
- (2017) Jung Soo Lee et al. Biomed Research International
- MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
- (2017) Manabu Mikamori et al. Scientific Reports
- Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic
- (2016) N. M. Teplyuk et al. EMBO Molecular Medicine
- Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
- (2016) Xiaodan Meng et al. Oncotarget
- Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression
- (2016) Zarin Nuzhat et al. Oncotarget
- The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
- (2015) Brock Humphries et al. Oncotarget
- MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II
- (2015) Sameer Abdallah Dhayat et al. Clinical Epigenetics
- MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
- (2015) Sameer A. Dhayat et al. PLoS One
- MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
- (2014) S Hasegawa et al. BRITISH JOURNAL OF CANCER
- Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity
- (2014) Bindhu Madhavan et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- miR-200–containing extracellular vesicles promote breast cancer cell metastasis
- (2014) Minh T.N. Le et al. JOURNAL OF CLINICAL INVESTIGATION
- The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?
- (2014) Sameer A. Dhayat et al. JOURNAL OF SURGICAL ONCOLOGY
- microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer
- (2013) Riccardo Cazzoli et al. Journal of Thoracic Oncology
- Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma
- (2013) Risheng Que et al. World Journal of Surgical Oncology
- Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
- (2012) Manuel Valladares-Ayerbes et al. Journal of Translational Medicine
- Impact of serum storage conditions on microRNA stability
- (2012) S Grasedieck et al. LEUKEMIA
- Loss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage
- (2011) Anne-Kathleen Rupp et al. GYNECOLOGIC ONCOLOGY
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started